Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 01/10/2026			5-day change	1st Jan Change
57.65 ^EUR	-3.11%		-3.27%	-8.93%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	2,936	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-9.62%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,927	2,863	2,750
Change	-	-54.48%	73.7%	1.65%	-1%	-10.54%	-2.19%	-3.95%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	19.4x	17x	13.8x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	3.9x	3.34x	2.86x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	2.54x	1.2x	0.6x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.79x	3.29x	3x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.78x	3.21x	2.81x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	14.8x	11.1x	8.81x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	17.8x	12.9x	9.97x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	23.3x	23.4x	16.6x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	4.29%	4.28%	6.04%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.9737	1.161	1.361
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.7%	2.02%	2.37%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.96	3.37	4.164
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	32.9%	34.5%	32.7%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	774.1	892.4	978
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	197.6	257.3	312.3
EBIT ¹	181.5	255.8	220.1	179.4	185.8	164.4	222.4	275.8
Net income ¹	153.1	199.7	170.3	136.9	140.4	146.2	172.9	213.8
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-8.499	-72.51	-185.6
Reference price ²	73.80	36.06	60.20	62.95	63.50	57.40	57.40	57.40
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,143	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%